Dhan App
Chrome
Pay ₹0 Brokerage on Investing. Open Free Demat Account with Zero AMC for Life!
+91
Healthcare Stocks
Last Updated on
Healthcare stocks represent companies providing medical services, pharmaceuticals, and medical equipment. These firms are vital for public health and medical advancements. When you explore healthcare stocks, you're viewing data on businesses that impact the well-being of people, offering insights into healthcare services and innovations in India.
All Companies in Healthcare Sector
CSV
View By:
CSV
Name | LTP | Change % | Volume | Market Cap (Cr.)  | PE Ratio | Industry PE | 52W High | 52W Low | 1M Returns | 3M Returns | 1 Yr Returns | 3 Yr Returns | 5 Yr Returns | PB Ratio | Dividend Yield | ROE | ROCE | EPS | 50 DMA | 200 DMA | RSI | MTF | Margin Pledge |
|---|
 S Sun Pharmaceutical | 1,638.90 | 0.43% | 26,66,522 | ₹ 3,93,227 | 37.34 | 17.77 | 1,851.20 | 1,548.00 | -6.66% | -3.02% | -10.62% | 56.19% | 179.48% | 5.03 | 0.98% | 14.38% | 18.92% | 43.95 | 1,751.47 | 1,695.13 | 32.48 | 78.00% | 91.00% |
 D Divis Laboratories | 6,056.00 | 0.74% | 3,67,912 | ₹ 1,60,768 | 64.15 | 40.77 | 7,071.50 | 4,955.00 | -6.49% | -7.76% | 3.50% | 78.87% | 69.68% | 10.34 | 0.50% | 11.79% | 18.85% | 63.06 | 6,397.94 | 6,346.27 | 31.96 | 76.00% | 87.50% |
 T Torrent Pharmaceuticals | 3,997.40 | 1.66% | 2,49,417 | ₹ 1,35,290 | 62.11 | 19.93 | 4,107.20 | 2,886.45 | 4.64% | 10.61% | 22.48% | 150.21% | 203.38% | 15.73 | 0.15% | 24.16% | 28.48% | 49.44 | 3,838.35 | 3,536.94 | 51.26 | 78.00% | 87.50% |
 C Cipla | 1,313.00 | -0.15% | 41,09,525 | ₹ 1,06,060 | 23.43 | 17.77 | 1,673.00 | 1,303.00 | -12.51% | -20.19% | -9.52% | 23.57% | 56.91% | 3.23 | 1.22% | 15.50% | 21.57% | 55.04 | 1,488.57 | 1,512.64 | 16.66 | 78.00% | 91.00% |
 D Dr Reddys Laboratories | 1,239.80 | 0.34% | 21,59,137 | ₹ 1,03,477 | 18.67 | 17.77 | 1,379.70 | 1,020.00 | -3.40% | -3.10% | -3.85% | 42.90% | 21.97% | 2.86 | 0.65% | 19.74% | 21.88% | 333.59 | 1,245.99 | 1,247.84 | 53.53 | 78.00% | 91.00% |
 L Lupin | 2,150.50 | 0.62% | 8,42,777 | ₹ 98,235 | 22.46 | 17.77 | 2,226.30 | 1,795.20 | 1.75% | 10.86% | -0.03% | 180.91% | 98.77% | 4.97 | 0.56% | 13.47% | 21.29% | 49.64 | 2,103.97 | 2,003.27 | 49.85 | 76.00% | 87.50% |
 A Apollo Hospitals | 6,793.50 | -0.14% | 5,15,312 | ₹ 97,680 | 56.56 | -62.77 | 8,099.50 | 6,001.00 | -3.96% | -14.75% | -1.84% | 56.70% | 152.84% | 10.76 | 0.19% | 12.53% | 15.53% | 72.05 | 7,180.53 | 7,320.22 | 32.67 | 75.00% | 91.00% |
 M Max Healthcare Institute | 975.50 | -1.60% | 42,29,886 | ₹ 94,894 | 71.08 | -62.77 | 1,314.30 | 940.05 | -9.27% | -19.45% | -9.91% | 119.73% | 501.23% | 9.60 | 0.15% | 14.89% | 11.73% | 10.84 | 1,076.94 | 1,154.17 | 32.96 | 70.00% | 87.40% |
 Z Zydus Life Science | 893.35 | 1.29% | 4,90,213 | ₹ 89,892 | 17.65 | 17.77 | 1,059.05 | 795.00 | -3.71% | -11.46% | -9.69% | 101.07% | 91.13% | 3.51 | 1.25% | 17.34% | 21.99% | 41.43 | 917.10 | 948.63 | 39.82 | 76.00% | 87.50% |
 M Mankind Pharma | 2,094.20 | -0.64% | 4,31,208 | ₹ 86,450 | 48.94 | 17.77 | 2,716.50 | 2,081.90 | -6.07% | -14.56% | -20.53% | 47.24% | 47.24% | 5.68 | - | 20.28% | 13.33% | 48.99 | 2,197.73 | 2,404.88 | 41.23 | 75.00% | 87.50% |
 A Alkem Laboratories | 5,754.00 | 0.06% | 99,479 | ₹ 68,798 | 28.50 | 17.77 | 5,933.50 | 4,491.65 | 2.81% | 3.98% | 11.01% | 88.88% | 85.00% | 5.15 | 0.78% | 16.91% | 19.29% | 179.80 | 5,666.40 | 5,300.87 | 54.24 | 78.00% | 87.50% |
 A Aurobindo Pharma | 1,129.70 | -0.25% | 6,56,428 | ₹ 65,613 | 19.24 | 17.77 | 1,278.60 | 1,010.00 | -7.25% | 2.78% | -9.25% | 153.38% | 13.13% | 1.88 | - | 10.62% | 15.74% | 61.22 | 1,198.46 | 1,144.72 | 37.32 | 76.00% | 87.50% |
 F Fortis Healthcare | 838.45 | -0.66% | 13,63,842 | ₹ 63,299 | 61.31 | -62.77 | 1,104.30 | 577.00 | -7.00% | -20.11% | 31.85% | 195.80% | 386.34% | 6.75 | 0.12% | 7.54% | 9.86% | 8.50 | 898.51 | 860.44 | 34.12 | 75.00% | 87.50% |
 A Abbott | 27,685.00 | -0.34% | 4,631 | ₹ 58,829 | 39.19 | 43.62 | 37,000.00 | 25,325.00 | -2.16% | -8.07% | -0.59% | 26.50% | 90.32% | 14.74 | 1.71% | 32.48% | 42.09% | 583.05 | 28,618.40 | 30,703.00 | 43.39 | 73.15% | 80.00% |
 G Glenmark Pharmaceuticals | 1,999.70 | 1.63% | 4,58,666 | ₹ 56,432 | 55.08 | 17.77 | 2,284.80 | 1,275.50 | -2.31% | 8.06% | 32.35% | 377.60% | 306.94% | 5.80 | 0.13% | 3.84% | 15.93% | - | 1,969.41 | 1,834.56 | 45.72 | 75.73% | 87.50% |
 L Laurus Labs | 1,000.20 | -1.59% | 53,89,025 | ₹ 53,996 | 80.53 | 17.77 | 1,141.00 | 501.15 | -6.38% | 7.04% | 70.93% | 186.67% | 163.52% | 11.43 | 0.12% | 4.09% | 12.08% | 2.75 | 1,038.46 | 842.76 | 42.20 | 75.20% | 80.00% |
 B Biocon | 365.25 | -0.26% | 33,33,643 | ₹ 48,833 | 77.96 | 17.77 | 424.95 | 291.00 | -9.04% | 0.81% | -8.07% | 47.07% | -4.56% | 1.57 | 0.10% | 5.13% | 6.26% | 13.00 | 390.67 | 363.81 | 37.98 | 75.63% | 87.50% |
 G GlaxoSmithKline Pharmaceuticals | 2,340.80 | 1.18% | 46,789 | ₹ 39,655 | 40.99 | 43.62 | 3,515.70 | 1,921.00 | -6.38% | -15.21% | 12.13% | 83.21% | 57.32% | 22.93 | 2.34% | 33.19% | 57.25% | 45.47 | 2,477.24 | 2,811.73 | 39.41 | 66.81% | 80.00% |
 I IPCA Laboratories | 1,454.90 | -0.54% | 62,993 | ₹ 36,911 | 43.48 | 17.77 | 1,595.00 | 1,168.20 | 1.37% | 13.95% | -8.12% | 66.90% | 46.84% | 5.00 | 0.27% | 6.85% | 12.97% | 23.14 | 1,448.65 | 1,397.88 | 48.94 | 70.25% | 80.00% |
 N Narayana Hrudayalaya | 1,725.90 | -1.19% | 2,67,296 | ₹ 35,271 | 42.28 | -62.77 | 2,370.20 | 1,260.00 | -8.03% | -1.93% | 30.05% | 136.52% | 275.11% | 8.80 | 0.26% | 27.37% | 17.82% | 39.47 | 1,899.02 | 1,841.53 | 33.46 | 69.67% | 80.00% |
 A Ajanta Pharma | 2,698.30 | -0.05% | 85,528 | ₹ 33,711 | 34.64 | 19.93 | 3,079.90 | 2,327.30 | 1.13% | 11.75% | -6.83% | 125.48% | 130.10% | 7.82 | 1.04% | 22.88% | 30.11% | 67.81 | 2,659.26 | 2,599.59 | 47.56 | 68.72% | 80.00% |
 A Anthem Biosciences | 592.40 | -2.71% | 2,57,179 | ₹ 33,270 | 66.29 | 17.77 | 873.50 | 587.10 | -11.53% | -17.47% | -18.89% | -18.89% | -18.89% | 12.43 | - | - | 26.89% | - | 648.73 | - | 39.37 | - | 70.00% |
 J J B Chemicals and Pharmaceuticals | 1,877.50 | 1.71% | 1,74,612 | ₹ 29,411 | 39.19 | 17.77 | 1,939.00 | 1,385.75 | 4.04% | 9.87% | 3.98% | 90.45% | 257.48% | 7.76 | 0.82% | 18.90% | 24.69% | 37.83 | 1,820.98 | 1,714.92 | 48.03 | 70.43% | 80.00% |
 A Aster DM Healthcare | 554.20 | -0.19% | 5,87,663 | ₹ 28,714 | 78.88 | -62.77 | 732.20 | 387.10 | -7.22% | -23.08% | 10.93% | 152.43% | 258.36% | 6.88 | 0.87% | 4.07% | 10.39% | 2.47 | 624.47 | 606.00 | 32.68 | 60.00% | 75.00% |
 E Emcure Pharmaceuticals | 1,484.60 | -3.02% | 1,95,509 | ₹ 28,143 | 35.18 | 17.77 | 1,585.60 | 889.00 | 4.07% | 7.19% | 10.32% | 9.23% | 9.23% | 6.08 | 0.20% | 16.90% | 20.62% | 26.63 | 1,435.42 | 1,327.03 | 57.52 | 60.00% | 80.00% |
 G Global Health | 1,042.90 | 1.25% | 1,96,929 | ₹ 28,032 | 49.30 | -62.77 | 1,456.50 | 1,001.00 | -12.21% | -22.95% | -2.55% | 133.86% | 151.12% | 7.47 | - | 13.43% | 17.18% | 17.97 | 1,178.70 | 1,256.31 | 28.73 | 60.00% | 75.00% |
 G Gland Pharma | 1,675.90 | -0.39% | 42,846 | ₹ 27,612 | 35.06 | 19.93 | 2,131.00 | 1,277.80 | -0.71% | -13.26% | 3.29% | 21.83% | -25.55% | 2.90 | 1.07% | 8.85% | 11.44% | 43.83 | 1,721.75 | 1,771.67 | 45.97 | 69.35% | 80.00% |
 K Krishna Institute of Medical Sciences | 615.00 | 5.65% | 7,24,790 | ₹ 24,609 | 65.49 | -62.77 | 798.40 | 474.05 | -4.03% | -14.61% | -0.55% | 114.17% | 208.44% | 10.26 | - | 16.05% | 13.23% | 39.48 | 648.66 | 686.21 | 32.23 | 65.00% | 80.00% |
 D Dr. Lal Path Labs | 1,401.40 | 1.82% | 2,12,535 | ₹ 23,481 | 42.69 | -62.77 | 1,770.00 | 1,146.78 | -0.69% | -8.75% | -2.60% | 30.12% | 22.78% | 9.65 | 0.87% | 19.22% | 27.96% | 45.65 | 1,471.82 | 1,499.27 | 39.81 | 71.39% | 80.00% |
 W Wockhardt | 1,348.60 | -0.22% | 4,36,426 | ₹ 21,914 | -428.63 | 17.77 | 1,868.80 | 1,110.05 | -6.66% | -0.75% | -5.70% | 527.84% | 194.47% | 4.79 | - | - | 3.91% | - | 1,377.74 | 1,458.21 | 43.19 | 59.62% | 75.00% |
 P Pfizer | 4,607.80 | 0.37% | 11,424 | ₹ 21,080 | 25.05 | 43.62 | 5,993.00 | 3,701.00 | -9.08% | -13.02% | -3.70% | 12.18% | -2.40% | 5.46 | 3.59% | 15.33% | 23.60% | 131.73 | 4,943.91 | 5,086.92 | 32.05 | 71.85% | 80.00% |
 A AstraZeneca Pharma | 8,349.00 | 0.36% | 7,395 | ₹ 20,873 | 104.27 | 43.62 | 10,691.00 | 6,620.10 | -8.65% | -10.24% | 18.00% | 143.04% | 132.45% | 25.99 | 0.39% | 22.69% | 19.36% | 52.40 | 8,851.05 | 8,887.47 | 36.47 | 60.00% | 75.00% |
 P Piramal Pharma | 152.45 | 0.69% | 46,39,402 | ₹ 20,264 | -841.11 | 17.77 | 251.95 | 150.21 | -14.36% | -25.12% | -36.40% | 40.26% | -17.84% | 2.49 | 0.09% | 0.23% | 7.02% | 0.30 | 176.14 | 195.88 | 24.73 | 72.62% | 80.00% |
 S Syngene International | 489.70 | -9.95% | 63,09,793 | ₹ 19,732 | 62.08 | 37.42 | 862.35 | 539.10 | -25.64% | -25.94% | -42.18% | -19.08% | -16.43% | 4.62 | 0.23% | 11.98% | 13.20% | 11.85 | 639.41 | 650.61 | 15.86 | 76.00% | 80.00% |
 E Eris Lifesciences | 1,343.20 | -3.06% | 1,50,450 | ₹ 18,297 | 42.77 | 19.93 | 1,910.00 | 1,097.20 | -13.45% | -15.50% | 7.75% | 111.43% | 119.64% | 5.46 | 0.52% | 16.85% | 12.74% | 27.95 | 1,546.76 | 1,606.75 | 30.09 | 68.93% | 80.00% |
 S Sai Life Sciences | 820.25 | 3.18% | 3,65,417 | ₹ 17,253 | 58.73 | 19.93 | 983.35 | 636.10 | -9.04% | -8.06% | 17.89% | 7.27% | 7.27% | 7.41 | - | - | 12.52% | - | 887.26 | 827.71 | 31.46 | 65.00% | 70.00% |
 N Neuland Laboratories | 12,796.00 | -3.43% | 36,988 | ₹ 16,417 | 70.76 | 40.77 | 19,747.00 | 10,190.70 | -16.51% | -21.00% | -7.66% | 729.67% | 832.59% | 10.49 | 0.09% | 23.39% | 20.69% | 249.83 | 15,685.10 | 14,131.06 | 30.48 | 36.00% | 70.00% |
 P Poly Medicure | 1,515.10 | -4.71% | 1,32,319 | ₹ 15,357 | 44.53 | -62.77 | 2,937.60 | 1,554.00 | -15.82% | -21.22% | -36.76% | 74.14% | 189.78% | 5.52 | 0.22% | 14.44% | 16.46% | 28.09 | 1,815.61 | 2,053.81 | 31.63 | 50.00% | 65.00% |
 J Jubilant Pharmova | 938.90 | -1.80% | 97,232 | ₹ 14,955 | 32.06 | 40.77 | 1,248.00 | 802.00 | -13.22% | -16.70% | -2.03% | 162.56% | 5.69% | 2.31 | 0.52% | 1.34% | 11.53% | 14.96 | 1,066.70 | 1,077.72 | 32.56 | 65.08% | 80.00% |
 A Alembic Pharmaceuticals | 757.30 | -0.95% | 35,416 | ₹ 14,886 | 23.73 | 17.77 | 1,107.90 | 725.20 | -11.67% | -17.82% | -22.57% | 35.33% | -21.24% | 2.82 | 1.44% | 12.78% | 14.66% | 32.05 | 856.72 | 923.26 | 22.60 | 67.21% | 80.00% |
 N Natco Pharma | 814.25 | -2.13% | 5,28,716 | ₹ 14,584 | 9.70 | 17.77 | 1,341.00 | 726.80 | -12.16% | -2.39% | -37.42% | 51.77% | -8.97% | 1.72 | 0.72% | 14.68% | 30.12% | 91.37 | 886.08 | 875.77 | 39.29 | 66.12% | 80.00% |
 C Cohance Lifesciences | 375.00 | -1.73% | 8,42,786 | ₹ 14,346 | 46.57 | 17.77 | 1,328.00 | 379.20 | -29.97% | -57.71% | -63.80% | -24.04% | -20.37% | 3.85 | - | 14.64% | 13.36% | 9.45 | 522.18 | 864.97 | 9.52 | 60.00% | 75.00% |
 A Acutaas Chemicals | 1,728.00 | 4.51% | 4,24,478 | ₹ 14,147 | 60.36 | 40.77 | 1,902.00 | 918.78 | 1.95% | -0.70% | 70.88% | 288.64% | 269.63% | 9.56 | 0.09% | 14.02% | 16.51% | 15.13 | 1,703.91 | 1,403.18 | 45.19 | 50.00% | 70.00% |
 D Dr. Agarwal's Health Care | 445.95 | -2.78% | 1,87,183 | ₹ 14,113 | 99.68 | -62.77 | 568.00 | 327.00 | -10.91% | -17.74% | 11.03% | 11.03% | 11.03% | 7.51 | - | - | 8.41% | - | 501.64 | 450.83 | 25.74 | 65.00% | 70.00% |
 G Granules | 579.10 | 2.50% | 20,05,231 | ₹ 14,053 | 26.74 | 17.77 | 627.00 | 422.00 | -5.81% | 3.94% | -3.42% | 85.52% | 66.07% | 3.44 | 0.27% | 12.57% | 17.96% | 20.30 | 576.32 | 521.86 | 43.60 | 74.22% | 80.00% |
 O Onesource Specialty Pharma | 1,151.30 | -19.62% | 29,44,215 | ₹ 13,192 | 410.50 | 17.77 | 2,248.00 | 1,209.95 | -33.50% | -37.46% | -32.67% | -32.67% | -32.67% | 2.78 | - | - | 1.54% | - | 1,689.60 | 1,798.21 | 21.36 | 60.00% | 70.00% |
 C Caplin Point Laboratories | 1,730.60 | 0.44% | 1,08,496 | ₹ 13,155 | 21.94 | 19.93 | 2,395.00 | 1,599.00 | -12.64% | -14.45% | -21.87% | 152.55% | 265.45% | 4.14 | 0.35% | 19.77% | 23.34% | 62.84 | 1,885.43 | 2,015.14 | 32.16 | 50.00% | 75.00% |
 C Concord Biotech | 1,222.00 | -2.08% | 48,693 | ₹ 12,784 | 40.31 | 17.77 | 2,451.70 | 1,224.60 | -9.07% | -19.21% | -42.49% | 29.61% | 29.61% | 7.13 | 0.70% | 20.18% | 26.76% | 29.94 | 1,370.88 | 1,598.40 | 34.43 | 50.00% | 70.00% |
 R Rainbow Childrens Medicare | 1,188.50 | 0.24% | 67,102 | ₹ 12,070 | 47.25 | -62.77 | 1,645.70 | 1,160.80 | -12.57% | -12.65% | -19.23% | 63.24% | 163.99% | 7.93 | 0.25% | 17.26% | 18.08% | 21.23 | 1,316.30 | 1,410.17 | 22.90 | 60.00% | 70.00% |
 I Indegene | 464.85 | -1.99% | 4,07,959 | ₹ 11,171 | 25.57 | 37.42 | 665.00 | 471.00 | -12.65% | -14.92% | -29.82% | -18.58% | -18.58% | 3.98 | 0.42% | 23.56% | 20.33% | 14.81 | 517.27 | 554.77 | 20.39 | 60.00% | 65.00% |
Showing 50 of 187 results
Please Note:
- PE Ratio: Share Price/Earning Per Share
- PB Ratio: Market Cap/Book Value
- ROE: Net Income/Shareholder's Equity
- ROCE: Earning Before Interest & Tax (EBIT)/Capital Employed
- EPS: (Net Income-Preferred Dividend)/Weighted Average Number of Shares Outstanding
- 50 DMA: Simple Moving Average of the past 50 days closing prices for a stock.
- 200 DMA: Simple Moving Average of the past 200 days closing prices for a stock.
- RSI: Relative Strength Index (14) is a momentum indicator to measure price changes to analyse overbought/oversold conditions.
- MTF: % Amount Funded by Dhan.
- Margin Pledge: % Collateral Benefit for Additional Margin.
*The scrips mentioned above are just for research purpose and not recommendations. Please do your own due diligence before investing.
About Healthcare stocks
Healthcare is one of those sectors that always remains resilient. The industry is essential for our well-being, so regardless of how the economy performs, the demand for quality healthcare continues to be high. This sector largely progresses based on the performance of hospitals, diagnostics, pharmaceuticals, and medical devices. No wonder healthcare stocks are a part of many resilient portfolios. Long-term investors understand the value of these companies and invest in quality stocks in the sector.
As the population of India continues to grow, lifestyle changes have become even more rapid. Access to medical services is essential, which keeps the healthcare sector moving forward. Investors who want to balance growth and stability often choose companies holding strong potential in the healthcare sector.
Healthcare sector in India
In India, the healthcare sector has evolved strongly over the decades. Today, it includes businesses beyond the ambit of hospitals and medicine producers. The industry is broad enough and includes diagnostics, contract research, medical technology, wellness services, and healthcare infrastructure. Some of the key aspects that have been strengthening the healthcare sector in India are the rising income of consumers and higher insurance coverage. Also, people are becoming health-conscious, which keeps the demand for quality healthcare rising.
Incentives from the government and the adoption of digital health are some of the other factors fuelling this growth. Today, many pharmaceutical businesses are exporting products in international markets, which has further strengthened the industry. This is why investors often consider healthcare sector stocks for long-term growth. It’s not a cyclical sector, and the demand is proportionate to necessity.
What are Healthcare stocks?
Healthcare stocks belong to companies that deliver medical products or services. This includes hospital chains and pharmaceutical manufacturers. Other key players in the healthcare sector include diagnostic labs, medical equipment manufacturers, and healthcare service providers.
Investors choose healthcare industry stocks that are associated with modern treatments and wellness solutions. While certain healthcare company stocks cater to the domestic market, others export medicines and medical devices to generate consistent revenue.
Benefits of investing in Healthcare stocks
One of the biggest advantages of investing in healthcare stocks is the stability it provides. Regardless of their economic conditions, people need healthcare for survival. Therefore, healthcare related stocks are relatively defensive compared to other sectors.
The long-term visibility of healthcare companies is yet another advantage. The demand for healthcare can be visualised through lifestyle diseases. Also, people now have better access to medical care, which keeps the demand increasing. The pricing power of good healthcare stocks strengthens their business models.
Another crucial driver for growth is innovation. In the healthcare industry, research-oriented companies develop new treatments and technologies that can help these companies grow beyond traditional boundaries. This mix of stability and innovation makes the top healthcare stocks appealing to investors.
Who should invest in Healthcare stocks?
If you are looking to create wealth in the long term with low volatility, you may consider investing in healthcare stocks. Investors who prefer businesses with consistent demand and can hold these stocks through multiple cycles find this space well-aligned with their approach.
So, if you are diversifying your portfolio, include good healthcare stocks as a stabiliser. Review the healthcare stocks list and focus on the time horizon through which you can stay invested.
Risks of buying Healthcare stocks
Although healthcare stocks are comparatively defensive, they are not completely free from risks. Unpredictability in pricing and approvals of medical equipment and drugs due to regulatory changes continues to be a risk. Other risks include margin pressure and compliance costs. Changing global norms can also affect the profitability of these companies. Carefully evaluate the healthcare sector stocks list and choose the ones that can adapt to these changes quickly.
Some businesses also depend heavily on research outcomes. In some cases, these outcomes are uncertain. As an investor, you need to find the best healthcare stocks that involve lower risks.
How to identify good Healthcare stocks?
When you buy healthcare stocks, evaluate the business model at the outset. Companies with diversified streams of revenue are likely to handle changes in the market better.
Evaluate companies with consistent earnings and low debt levels. Also, check the long-term return ratios of healthcare firms.
When you assess companies from the list of healthcare stocks, take a look at their project pipelines. Also, evaluate their track record considering the regulations in the industry. When you assess these healthcare shares, always prioritise quality over valuation.
The bottom line
The healthcare industry gives you the opportunity to invest in a sector that grows along with an increase in population and economic progress. This sector brings you different opportunities to capitalise on, ranging from diagnostics to pharmaceuticals.
Before you buy healthcare stocks, take time to understand how these businesses operate and from where they generate revenue. Analyse promising players from the healthcare shares list and shortlist the ones that fit into your long-term investment strategy.
FAQs on Healthcare Stocks
Healthcare stocks provide investment opportunities in shares of companies operating in the healthcare sector, which includes pharmaceuticals, biotechnology, medical devices, hospitals, healthcare services, and health insurance.
Investing in healthcare stocks offers several advantages. The healthcare sector is essential and has a strong long-term growth potential driven by factors such as an aging population, technological advancements, and increasing healthcare expenditures. Companies in this sector can benefit from a steady demand for their products and services.
There are risks associated with investing in healthcare stocks. Regulatory changes, patent expirations, pricing pressures, and clinical trial outcomes can impact pharmaceutical and biotechnology companies. Healthcare providers face challenges related to reimbursement rates, competition, and regulatory compliance. Market volatility and geopolitical factors can also influence the healthcare sector.
Investors who believe in the long-term growth prospects of the healthcare industry and have an interest in contributing to advancements in healthcare may consider investing in healthcare stocks. It's important to assess a company's research pipeline, product portfolio, regulatory compliance, financial stability, and competitive position within the healthcare sector.
Join our Community
Follow us on
Partner with us
built with love
for Indians who love to invest & trade
We are part of Raise Financial Services
Explore | Sitemap
*All securities mentioned on this website are exemplary and not recommendatory.
*Current prices on the website are delayed by 15 mins, login to check live prices.
We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.
Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.
That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.
©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services.
SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.
For any query / feedback / clarifications, email at help@dhan.co.
Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details
Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.
Details of client bank account
For any query / feedback / clarifications, email at help@dhan.co.
In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.
Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.
DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances
Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit
Attention investors:
- Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
- Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
- Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.
Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.
Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.
Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account.
Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/
Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX
Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets
Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details
Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors